Amy Paturel, M.S., M.P.H.

Family history of breast and other cancers can mean some people are more likely to develop the disease at a younger age. But advances in testing may improve prevention and survival rates.

New treatments may stall lung cancer progression in patients with EGFR exon 20 insertion mutations.

Studies show that quitting smoking after a lung cancer diagnosis has a huge payoff for patients. Many smoking cessation programs in cancer centers have tools to help patients quit.

After decades of research, scientists inch closer to FDA approval for PSMA-targeted treatments that show promise for patients with an advanced form of prostate cancer.

First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.

A rare virus coupled with an ailing immune system can lead to Kaposi’s sarcoma. Restoring immune function can help fight it.